Take Action

Sign ITPC’s petition to Gilead

A recent decision by India’s Patent Office rejecting one of Gilead’s key patents for sofosbuvir is an important step for treatment activists. But Gilead is using every trick in the book to get the decision reversed, including lobbying the Indian Government.
Sign our petition today to expand Hep C treatment!

More from  Updates

Together, we can do more!

Whether you’re a philanthropist looking to make a one-time contribution or an institutional donor interested in providing on-going support, every dollar counts! We can carry out this strategic plan faster and reach even further with you as a significant force propelling us forward.

Donate here